Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases-Reference-Cited by-同舟云学术

Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases

Published:2022-09 Issue: Volume:239 Page:114551
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Shen Pei,Wang Yezhi,Jia Xiangxiang,Xu Pengfei,Qin Lian,Feng Xi,Li Zhiyu,Qiu Zhixia

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference191 articles.

1. The janus kinases (Jaks);Yamaoka;Genome Biol.,2004

2. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases;Clark;J. Med. Chem.,2014

3. The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders;Furumoto;BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,2013

4. Janus kinases in immune cell signaling;Ghoreschi;Immunol. Rev.,2009

5. Janus kinase inhibitors in autoimmune diseases;O'Shea;Ann. Rheum. Dis.,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of novel pyrrolo[2,3-d]pyrimidine derivatives as potent JAK3 and SYK dual inhibitors;Journal of Molecular Structure;2024-12

2. Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship;Bioorganic Chemistry;2024-11

3. Emerging Therapeutics in Chronic Urticaria;Immunology and Allergy Clinics of North America;2024-08

4. Current status of drugs targeting PDGF/PDGFR;Drug Discovery Today;2024-07

5. Cell Model Representatives of Pediatric Neuroblastoma: Evidence from Transcriptomic Ranking and Pharmacogenomic Connectivity Analysis;2024-06-26